Kenneth Christensen Email and Phone Number
Chief Scientific Officer Head Research And Development
at
Contera Pharma
Kenneth Christensen's email is kchristensen@lundbeck.com
.
Kenneth Christensen Contact Details
Email
kchristensen@lundbeck.com
Email
kvchristensen@gmail.com
Email
kec4000@gmail.com
Email
kenneth.christensen@servier.com
Kenneth Christensen Company Details
Location
København, Capital Region, Denmark
Industry
Biotechnology
Kenneth Christensen's Experience and Education
Work Experience
Chief Scientific Officer Head Research And Development
2020-12 to Unknown
København, Capital Region, Denmark
Research Program Director Head Of Neurology Research
2020-10 to 2020-12
Suresnes, Ile De France, France
Research Program Director Movement Disorders
2019-11 to 2020-09
Suresnes, Ile De France, France
Education
Zealand Sjællands Erhvervsakademi
2013 to 2013
Køge, Zealand, Denmark
Doctor Of Philosophy in Neuroscience
2001 to 2005
Denmark
Frequently Asked Questions about Kenneth Christensen
What company does Kenneth Christensen work for?
Kenneth Christensen works for Contera Pharma
What is Kenneth Christensen's role in his workplace?
Kenneth Christensen's role in his workplace is
Chief Scientific Officer Head Research And Development .
Which industry does Kenneth Christensen work in currently?
Kenneth Christensen works in the industry
Biotechnology.
What is Kenneth Christensen's email address?
Kenneth Christensen's email address is kchristensen@lundbeck.com
What schools did Kenneth Christensen attended?
Kenneth Christensen attended
Zealand Sjællands Erhvervsakademi,
Aarhus University,
and
Københavns Universitet University Of Copenhagen.
What are some of Kenneth Christensen's skills?
Kenneth Christensen has skills like
Drug Discovery,
Project Management,
Neuropsychiatric Disorders,
Neurodegenerative Disorders,
Molecular Neuroscience,
Molecular Biology,
Rnaseq,
Dna Microarray,
Qpcr,
Cell Biology,
Molecular Pharmacology,
Neurodegeneration,
Structural Biology,
Neuropharmacology,
Pharmaceutical Industry,
Pharmacology,
Neuroscience,
Cro Management,
Translational Research,
Drug Development,
and
In Vitro.
